Nobel Financials
This page shows Nobel (NBLWF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Nobel has an operating margin of 12.7%, meaning the company retains $13 of operating profit per $100 of revenue. This results in a moderate score of 50/100, indicating healthy but not exceptional operating efficiency. This is down from 19.8% the prior year.
Nobel's revenue grew 7.4% year-over-year to $3.3B, a solid pace of expansion. This earns a growth score of 46/100.
Nobel carries a low D/E ratio of 0.43, meaning only $0.43 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 93/100, indicating a strong balance sheet with room for future borrowing.
Nobel's current ratio of 1.67 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 29/100, which could limit financial flexibility.
Nobel generates a 4.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 22/100. This is down from 9.6% the prior year.
Nobel passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Nobel generates $4.39 in operating cash flow ($951.7M OCF vs $216.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Nobel earns $2.6 in operating income for every $1 of interest expense ($415.6M vs $162.4M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Nobel generated $3.3B in revenue in fiscal year 2025. This represents an increase of 7.4% from the prior year.
Nobel reported $216.7M in net income in fiscal year 2025. This represents a decrease of 51.7% from the prior year.
Nobel earned $1.35 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 54.4% from the prior year.
Cash & Balance Sheet
Nobel held $471.4M in cash against $2.0B in long-term debt as of fiscal year 2025.
Nobel paid $2.00 per share in dividends in fiscal year 2025. This represents an increase of 11.1% from the prior year.
Nobel had 159M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Margins & Returns
Nobel's operating margin was 12.7% in fiscal year 2025, reflecting core business profitability. This is down 7.1 percentage points from the prior year.
Nobel's net profit margin was 6.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 8.1 percentage points from the prior year.
Nobel's ROE was 4.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 4.9 percentage points from the prior year.
Capital Allocation
Nobel spent $20.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 93.3% from the prior year.
NBLWF Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $764.4M-4.2% | $798.0M-6.0% | $848.7M-3.0% | $874.5M-5.7% | $927.3M+15.8% | $800.5M+15.5% | $692.8M+8.8% | $637.1M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $29.7M-10.9% | $33.3M-4.8% | $35.0M-0.7% | $35.2M+12.6% | $31.3M-28.3% | $43.6M+9.9% | $39.7M+52.8% | $26.0M |
| Operating Income | $42.6M-15.6% | $50.4M-62.7% | $135.3M-27.8% | $187.3M+9.6% | $171.0M+48.1% | $115.5M-45.0% | $210.0M+95.2% | $107.5M |
| Interest Expense | $41.4M+2.4% | $40.5M+1.2% | $40.0M-1.2% | $40.5M+1.9% | $39.7M+59.2% | $25.0M+108.0% | $12.0M-31.6% | $17.5M |
| Income Tax | -$72.8M-329.6% | $31.7M-44.4% | $57.1M+41.3% | $40.4M+45.3% | $27.8M-12.0% | $31.6M+704.6% | -$5.2M+48.8% | -$10.2M |
| Net Income | $86.6M+510.7% | -$21.1M-149.2% | $42.9M-60.4% | $108.3M+12.1% | $96.6M+57.9% | $61.2M-68.6% | $195.0M+104.2% | $95.5M |
| EPS (Diluted) | N/A | $-0.13-148.1% | $0.27-59.7% | $0.67 | N/A | $0.40-70.1% | $1.34+103.0% | $0.66 |
NBLWF Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.5B-1.4% | $7.6B-0.4% | $7.7B-3.1% | $7.9B-0.7% | $8.0B-0.9% | $8.0B+43.8% | $5.6B+2.8% | $5.4B |
| Current Assets | $1.3B-6.8% | $1.4B+5.8% | $1.3B-10.7% | $1.4B+3.9% | $1.4B-1.5% | $1.4B+42.9% | $986.9M+1.6% | $971.1M |
| Cash & Equivalents | $471.4M-1.4% | $477.9M+41.3% | $338.2M+11.3% | $303.8M+22.8% | $247.3M-36.9% | $391.9M+140.6% | $162.9M-23.4% | $212.5M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $589.6M-13.1% | $678.3M-11.0% | $761.7M+0.7% | $756.3M-5.1% | $797.0M+5.9% | $752.3M+18.1% | $637.0M+7.9% | $590.2M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $3.0B-4.0% | $3.1B+2.2% | $3.0B-6.6% | $3.3B-1.9% | $3.3B-1.1% | $3.4B+109.1% | $1.6B+5.2% | $1.5B |
| Current Liabilities | $759.7M-2.5% | $779.3M+8.8% | $716.0M-22.2% | $920.0M-2.2% | $940.4M+4.4% | $900.5M+41.4% | $637.0M+5.6% | $603.4M |
| Long-Term Debt | $2.0B-0.1% | $2.0B-0.1% | $2.0B0.0% | $2.0B-0.1% | $2.0B-0.1% | $2.0B+218.5% | $622.1M+6.0% | $586.6M |
| Total Equity | $4.5B+0.3% | $4.5B-2.0% | $4.6B-0.6% | $4.7B+0.1% | $4.7B-0.7% | $4.7B+17.6% | $4.0B+1.8% | $3.9B |
| Retained Earnings | $286.6M+2.3% | $280.1M-26.6% | $381.5M-9.1% | $419.6M+2.0% | $411.2M-7.6% | $445.1M-30.9% | $643.9M+11.2% | $578.9M |
NBLWF Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $187.1M-32.5% | $277.1M+28.1% | $216.4M-20.2% | $271.1M+99.0% | $136.2M-52.0% | $283.8M+165.7% | $106.8M-17.0% | $128.7M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$106.4M-104.8% | -$52.0M+44.5% | -$93.6M+4.7% | -$98.1M+32.4% | -$145.2M+71.7% | -$514.0M-285.9% | -$133.2M+20.1% | -$166.6M |
| Financing Cash Flow | -$85.3M+1.0% | -$86.1M-0.1% | -$86.1M+26.1% | -$116.5M+19.0% | -$143.8M-130.8% | $466.8M+2213.9% | -$22.1M+80.4% | -$112.8M |
| Dividends Paid | $79.9M+0.5% | $79.5M0.0% | $79.5M-2.3% | $81.4M+2.2% | $79.7M-2.3% | $81.6M-37.2% | $129.9M+118.7% | $59.4M |
| Share Buybacks | $0 | $0 | $0-100.0% | $20.0M-60.0% | $50.0M-80.0% | $250.0M | $0 | $0 |
NBLWF Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 5.6%-0.8pp | 6.3%-9.6pp | 15.9%-5.5pp | 21.4%+3.0pp | 18.4%+4.0pp | 14.4%-15.9pp | 30.3%+13.4pp | 16.9% |
| Net Margin | 11.3%+14.0pp | -2.6%-7.7pp | 5.1%-7.3pp | 12.4%+2.0pp | 10.4%+2.8pp | 7.6%-20.5pp | 28.1%+13.2pp | 15.0% |
| Return on Equity | 1.9%+2.4pp | -0.5%-1.4pp | 0.9%-1.4pp | 2.3%+0.3pp | 2.1%+0.8pp | 1.3%-3.6pp | 4.9%+2.4pp | 2.4% |
| Return on Assets | 1.1%+1.4pp | -0.3%-0.8pp | 0.6%-0.8pp | 1.4%+0.2pp | 1.2%+0.4pp | 0.8%-2.7pp | 3.5%+1.7pp | 1.8% |
| Current Ratio | 1.67-0.1 | 1.75-0.0 | 1.80+0.2 | 1.57+0.1 | 1.48-0.1 | 1.57+0.0 | 1.55-0.1 | 1.61 |
| Debt-to-Equity | 0.430.0 | 0.440.0 | 0.430.0 | 0.420.0 | 0.430.0 | 0.42+0.3 | 0.160.0 | 0.15 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
What is Nobel's annual revenue?
Nobel (NBLWF) reported $3.3B in total revenue for fiscal year 2025. This represents a 7.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Nobel's revenue growing?
Nobel (NBLWF) revenue grew by 7.4% year-over-year, from $3.1B to $3.3B in fiscal year 2025.
Is Nobel profitable?
Yes, Nobel (NBLWF) reported a net income of $216.7M in fiscal year 2025, with a net profit margin of 6.6%.
How much debt does Nobel have?
As of fiscal year 2025, Nobel (NBLWF) had $471.4M in cash and equivalents against $2.0B in long-term debt.
What is Nobel's operating margin?
Nobel (NBLWF) had an operating margin of 12.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Nobel's net profit margin?
Nobel (NBLWF) had a net profit margin of 6.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Nobel pay dividends?
Yes, Nobel (NBLWF) paid $2.00 per share in dividends during fiscal year 2025.
What is Nobel's return on equity (ROE)?
Nobel (NBLWF) has a return on equity of 4.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Nobel's operating cash flow?
Nobel (NBLWF) generated $951.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Nobel's total assets?
Nobel (NBLWF) had $7.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What is Nobel's current ratio?
Nobel (NBLWF) had a current ratio of 1.67 as of fiscal year 2025, which is generally considered healthy.
What is Nobel's debt-to-equity ratio?
Nobel (NBLWF) had a debt-to-equity ratio of 0.43 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Nobel's return on assets (ROA)?
Nobel (NBLWF) had a return on assets of 2.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Nobel's Piotroski F-Score?
Nobel (NBLWF) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Nobel's earnings high quality?
Nobel (NBLWF) has an earnings quality ratio of 4.39x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Nobel cover its interest payments?
Nobel (NBLWF) has an interest coverage ratio of 2.6x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Nobel?
Nobel (NBLWF) scores 48 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.